Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12015-010-9208-4.

Title:
The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells | Stem Cell Reviews and Reports
Description:
Normal stem cells and cancer stem cells (CSCs) share similar properties, in that both have the capacity to self-renew and differentiate into multiple cell types. In both the normal stem cell and cancer stem cell fields, there has been a great need for a universal marker that can effectively identify and isolate these rare populations of cells in order to characterize them and use this information for research and therapeutic purposes. Currently, it would appear that certain isoenzymes of the aldehyde dehydrogenase (ALDH) superfamily may be able to fulfill this role as a marker for both normal and cancer stem cells. ALDH has been identified as an important enzyme in the protection of normal hematopoietic stem cells, and is now also widely used as a marker to identify and isolate various types of normal stem cells and CSCs. In addition, emerging evidence suggests that ALDH1 is not only a marker for stem cells, but may also play important functional roles related to self-protection, differentiation, and expansion. This comprehensive review discusses the role that ALDH plays in normal stem cells and CSCs, with focus on ALDH1 and ALDH3A1. Discrepancies in the functional themes between cell types and future perspectives for therapeutic applications will also be discussed.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We're unsure if the website is profiting.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {πŸ”}

google, scholar, pubmed, cells, cas, cancer, stem, aldehyde, dehydrogenase, human, cell, research, breast, aldh, journal, activity, hematopoietic, retinoic, acid, normal, marker, molecular, blood, expression, identification, tumor, gene, high, article, role, aldha, progenitor, sladek, clinical, functional, differentiation, nature, pharmacology, class, malignant, prostate, allan, properties, biochemical, medicine, resistance, cellular, chemotherapy, ontario, biology,

Topics {βœ’οΈ}

ccaat/enhancer-binding protein beta major retinoic-acid-synthesizing enzyme primitive haematopoietic cells human colon-cancer-initiating cells stem/progenitor cell properties small-cell lung cancer anti-apoptotic protein bcl-2 malignant cancer-initiating cells tumor necrosis factor spg21 protein acp33/maspardin month download article/chapter bone marrow cells htert-immortalized primary nonmalignant retinoid signaling induces aldehyde dehydrogenase class-1a1 cell stem cell initiating tumor growth aldehyde-dehydrogenase gene transfer cd34+cd38-cd19+ cells hematopoietic repopulating cells pyridoxine-dependent epilepsy cancer stem cells cancer stem cell heart rate variability high aldehyde dehydrogenase tumor initiating cells tumor-initiating cells hematopoietic progenitor cells trans-retinoic acid trans retinoic acid normal stem cells stem cell rev regulates aldehyde dehydrogenase normal stem cell human epithelial cancers human progenitor cells negative estrogen receptor breast cancer cells enhanced aggressive properties human prostate cancer metastasis-initiating cells stem cell marker aldehyde dehydrogenase activity stem cell function high ki67 expression tumour-initiating cells cyclophosphamide-resistant l1210 leukemia murine hematopoietic progenitors cancer chemotherapeutic regimens human aldehyde dehydrogenase

Questions {❓}

  • If cancer stem cells are resistant to current therapies, what’s next?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
         description:Normal stem cells and cancer stem cells (CSCs) share similar properties, in that both have the capacity to self-renew and differentiate into multiple cell types. In both the normal stem cell and cancer stem cell fields, there has been a great need for a universal marker that can effectively identify and isolate these rare populations of cells in order to characterize them and use this information for research and therapeutic purposes. Currently, it would appear that certain isoenzymes of the aldehyde dehydrogenase (ALDH) superfamily may be able to fulfill this role as a marker for both normal and cancer stem cells. ALDH has been identified as an important enzyme in the protection of normal hematopoietic stem cells, and is now also widely used as a marker to identify and isolate various types of normal stem cells and CSCs. In addition, emerging evidence suggests that ALDH1 is not only a marker for stem cells, but may also play important functional roles related to self-protection, differentiation, and expansion. This comprehensive review discusses the role that ALDH plays in normal stem cells and CSCs, with focus on ALDH1 and ALDH3A1. Discrepancies in the functional themes between cell types and future perspectives for therapeutic applications will also be discussed.
         datePublished:2010-11-20T00:00:00Z
         dateModified:2010-11-20T00:00:00Z
         pageStart:292
         pageEnd:306
         sameAs:https://doi.org/10.1007/s12015-010-9208-4
         keywords:
            Aldehyde dehydrogenase (ALDH)
            Stem cells
            Cancer stem cells (CSCs)
            Retinoic acid (RA) signaling
            All-trans retinoic acid (ATRA)
            Self-protection
            Differentiation
            Expansion
            Stem Cells
            Regenerative Medicine/Tissue Engineering
            Cell Biology
            Biomedical Engineering and Bioengineering
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12015-010-9208-4/MediaObjects/12015_2010_9208_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12015-010-9208-4/MediaObjects/12015_2010_9208_Fig2_HTML.gif
         isPartOf:
            name:Stem Cell Reviews and Reports
            issn:
               1558-6804
               1550-8943
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Irene Ma
               affiliation:
                     name:University of Western Ontario
                     address:
                        name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
                        type:PostalAddress
                     type:Organization
                     name:London Health Sciences Centre
                     address:
                        name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alison L. Allan
               affiliation:
                     name:University of Western Ontario
                     address:
                        name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Western Ontario
                     address:
                        name:Department of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
                        type:PostalAddress
                     type:Organization
                     name:London Health Sciences Centre
                     address:
                        name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
      description:Normal stem cells and cancer stem cells (CSCs) share similar properties, in that both have the capacity to self-renew and differentiate into multiple cell types. In both the normal stem cell and cancer stem cell fields, there has been a great need for a universal marker that can effectively identify and isolate these rare populations of cells in order to characterize them and use this information for research and therapeutic purposes. Currently, it would appear that certain isoenzymes of the aldehyde dehydrogenase (ALDH) superfamily may be able to fulfill this role as a marker for both normal and cancer stem cells. ALDH has been identified as an important enzyme in the protection of normal hematopoietic stem cells, and is now also widely used as a marker to identify and isolate various types of normal stem cells and CSCs. In addition, emerging evidence suggests that ALDH1 is not only a marker for stem cells, but may also play important functional roles related to self-protection, differentiation, and expansion. This comprehensive review discusses the role that ALDH plays in normal stem cells and CSCs, with focus on ALDH1 and ALDH3A1. Discrepancies in the functional themes between cell types and future perspectives for therapeutic applications will also be discussed.
      datePublished:2010-11-20T00:00:00Z
      dateModified:2010-11-20T00:00:00Z
      pageStart:292
      pageEnd:306
      sameAs:https://doi.org/10.1007/s12015-010-9208-4
      keywords:
         Aldehyde dehydrogenase (ALDH)
         Stem cells
         Cancer stem cells (CSCs)
         Retinoic acid (RA) signaling
         All-trans retinoic acid (ATRA)
         Self-protection
         Differentiation
         Expansion
         Stem Cells
         Regenerative Medicine/Tissue Engineering
         Cell Biology
         Biomedical Engineering and Bioengineering
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12015-010-9208-4/MediaObjects/12015_2010_9208_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12015-010-9208-4/MediaObjects/12015_2010_9208_Fig2_HTML.gif
      isPartOf:
         name:Stem Cell Reviews and Reports
         issn:
            1558-6804
            1550-8943
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Irene Ma
            affiliation:
                  name:University of Western Ontario
                  address:
                     name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
                     type:PostalAddress
                  type:Organization
                  name:London Health Sciences Centre
                  address:
                     name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alison L. Allan
            affiliation:
                  name:University of Western Ontario
                  address:
                     name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Western Ontario
                  address:
                     name:Department of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
                     type:PostalAddress
                  type:Organization
                  name:London Health Sciences Centre
                  address:
                     name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Stem Cell Reviews and Reports
      issn:
         1558-6804
         1550-8943
      volumeNumber:7
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Western Ontario
      address:
         name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
         type:PostalAddress
      name:London Health Sciences Centre
      address:
         name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
         type:PostalAddress
      name:University of Western Ontario
      address:
         name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
         type:PostalAddress
      name:University of Western Ontario
      address:
         name:Department of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
         type:PostalAddress
      name:London Health Sciences Centre
      address:
         name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Irene Ma
      affiliation:
            name:University of Western Ontario
            address:
               name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
               type:PostalAddress
            type:Organization
            name:London Health Sciences Centre
            address:
               name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
               type:PostalAddress
            type:Organization
      name:Alison L. Allan
      affiliation:
            name:University of Western Ontario
            address:
               name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
               type:PostalAddress
            type:Organization
            name:University of Western Ontario
            address:
               name:Department of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
               type:PostalAddress
            type:Organization
            name:London Health Sciences Centre
            address:
               name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
      name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
      name:Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
      name:Department of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
      name:London Regional Cancer Program, London Health Sciences Centre, London, Canada
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(262)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.29s.